Owing to rising demand for ambulatory infusion pumps, increasing incidence of chronic diseases coupled with the rapid growth in the geriatric population, growing number of surgical procedures, and rising demand for home healthcare services, infusion pumps market has witnessed a steady growth. Further, growing adoption of specialty infusion systems and increasing demand of infusion pumps in the emerging markets provides high growth opportunities for the various stakeholders in this market.
Rising Demand for Ambulatory Infusion Pumps is propelling the Growth of Global Infusion Pumps Market
Ambulatory infusion pumps are an important means of drug delivery in a wide range of clinical conditions. They play a vital role in delivering pain control medication, TPN infusion, chemotherapy, and other infusions to patients in both inpatient and outpatient settings. In developed markets, the trend is shifting away from the hospital environment towards outpatient care, in order to reduce high treatment costs. As the demand for the outpatient and home care increases, ambulatory pumps are likely to witness high demand.
Growing Number of Surgical Procedures Support the Market Growth
The rate of surgical procedures continues to increase annually across the globe. According to Australian Institute of Health and Welfare, in 2015-2016, there were 3,281 surgical procedures and 4,154 chemotherapy procedures for brain and other CNS cancer. Males had a higher proportion of surgical procedures than females (61% compared with 39%). According to the Lancet Commission on Global Surgery, 143 million additional surgical procedures are needed each year to save lives and prevent disability by 2030. Factors that contributed to this increase are medical and technological advancements, including improvements in anesthesia and in analgesics for the relief of pain, and the development & expansion of minimally invasive and noninvasive procedures. Thus, rising number of surgical procedures has positively impacted the infusion pump market globally.
Click Here to Download Research Report Sample
Key Findings in the Global Infusion Pump Market Study:
Accessories/Consumables Generated large Proportion of the Revenue
In 2017, the accessories/consumables segment accounted for the largest share of the infusion pumps market in 2017 and is expected to grow at a highest CAGR during the forecast period. Recurrent use and repeat purchase of accessories/consumables for infusion therapy supports the high share of this segment.
Chemotherapy Commanded the Largest Share in the Infusion Pumps market
The chemotherapy segment accounted for the largest share of the global infusion pump market in 2017. The large share of this segment can be attributed to the growing incidence of cancer, increasing availability of ambulatory infusion pumps for chemotherapy, and the introduction of technologically advanced products in this market segment.
Hospitals to Dominate Global Infusion Pumps Market
Hospitals commanded the largest share of global infusion pump market in 2017 with the high purchasing power of hospitals for high-priced infusion devices, large patient pool, and the availability of trained professionals to operate infusion pumps. Home health care is expected to grow at a highest CAGR during the forecast period. Worldwide government initiatives to reduce the overall healthcare cost associated with longer hospital stays support the growing demand for infusion systems in the home health care segment.
Asia-Pacific: Fastest growing regional market
North America commanded the largest share of the global infusion pumps market in 2017, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. However, Asia-Pacific will be the fastest growing regional market due to the rising geriatric population, growing incidence of chronic diseases, increased accessibility to advanced healthcare facilities, rising healthcare spending, rapidly improving health insurance sector, growing demand for advanced technologies, and expansion of private-sector hospitals to rural areas are fueling the demand for infusion devices in this region. Further development in infusion technology has enabled infusion systems to connect to the electronic medical record via interoperability software. Interoperability software provides the ability to communicate and exchange data accurately, effectively, securely, and consistently with different information technology systems, software applications, and networks in various settings. In upcoming years, this advancement will increase the practices and demand of infusion pumps which will propel the infusion pumps market in future.
Key Players
The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 5 years. The key players profiled in the global infusion pumps market research report is Becton, Dickinson and Company (BD), B. Braun Melsungen, Baxter International, Fresenius Kabi, ICU Medical, Medtronic, Moog Inc., Smiths Medical, Terumo Corporation, Roche Diagnostics, and Halyard Health.
Key questions answered in the report:
Volumetric infusion pumps and related accessories dominated the infusion pumps market
Asia Pacific market favors both regional and local manufacturers that compete in multiple segments
Strategic collaborations and agreements have taken place in the infusion pumps market
We are in the phase of updating this report by analysing the impact of COVID-19 on this market.
1. Introduction
1.1. Market Ecosystem
1.2. Currency & Limitation
1.2.1. Currency
1.2.2. Limitation
1.3. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary
4. Market Insights
4.1. Drivers
4.1.1. Rising Demand for Ambulatory Infusion Pumps
4.1.2. Increasing Incidence of Chronic Diseases Along With the Rapid Growth in the Geriatric Population
4.1.3. Growing Number of Surgical Procedures Performed
4.1.4. Increase in awareness towards home healthcare
4.2. Restraint
4.2.1. Frequent Product Recalls of Infusion Pumps
4.2.2. Stringent Regulatory Requirements for New Products
4.2.3. Increasing Adoption of Refurbished and Rental Infusion Pumps
4.3. Opportunities
4.3.1. Emerging Markets
4.3.2. Growing Adoption of Specialty Infusion Systems
4.4. Challenges
4.4.1. Increasing Incidence of Medication Errors and Lack of Wireless Connectivity in Hospitals
5. Infusion Pumps Market, By Product
5.1. Devices
5.1.1. Volumetric Infusion Pumps
5.1.2. Syringe Infusion Pumps
5.1.3. Insulin Infusion Pumps
5.1.4. Ambulatory Infusion Pumps
5.1.4.1. Disposable Infusion Pumps
5.1.4.2. Chemotherapy Infusion Pumps
5.1.5. Enteral Infusion Pumps
5.1.6. Pca Infusion Pumps
5.1.7. Implantable Infusion Pumps
5.2. Infusion Pump Accessories/Consumables
5.2.1. Dedicated Accessories/Consumables
5.2.1.1. Volumetric Infusion Pump Accessories/Consumables
5.2.1.2. Enteral Infusion Pump Accessories/Consumables
5.2.1.3. Insulin Infusion Pump Accessories/Consumables
5.2.1.4. Syringe Infusion Pump Accessories/Consumables
5.2.1.5. Ambulatory Infusion Pump Accessories/Consumables
5.2.1.6. Pca Pump Accessories/Consumables
5.2.1.7. Implantable Infusion Pump Accessories/Consumables
5.2.2. Non-Dedicated Accessories/Consumables
5.2.2.1. Infusion Catheters
5.2.2.2. IV/Administration Sets
5.2.2.3. Needleless Connectors
5.2.2.4. Cannulas
5.2.2.5. Tubing and Extension Sets
5.2.2.6. Valves
5.2.2.7. Other Non-Dedicated Accessories/Consumables
5.3. Smart Infusion Systems
6. Infusion Pumps Market, By Channel
6.1. Introduction
6.2 .Single Channel
6.3. Multi Channel
7. Infusion Pumps Market, By Application
7.1. Introduction
7.2. Hormones
7.3. Antibiotics
7.4. Chemotherapy drugs
7.5. Pain Relievers
7.6. Others
8. Infusion Pumps Market, By End user
8.1. Introduction
8.2. Hospitals
8.3. Home Health Care
8.4. Ambulatory Care Settings
8.5. Academic & Research Institutes
8.6. Other
9. Infusion Pumps Market, By Geography
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. U.K.
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Latin America
9.4.2. Middle East & Africa
10. Competitive Landscape
10.1. New Product Launches
10.2. Agreements, Partnerships & Collaboration
10.3. Expansions
10.4. Mergers & Acquisitions
11. Company Profile
11.1. Becton, Dickinson and Company (BD)
11.2. B. Braun Melsungen
11.3. Baxter International
11.4. Fresenius Kabi
11.5. ICU Medical
11.6. Medtronic
11.7. Moog Inc. (Moog)
11.8. Smiths Medical (A Division of Smiths Group PLC)
11.9. Terumo Corporation
11.10. Roche Diagnostics (A Division of F. Hoffmann-LA Roche Ltd.)
11.11. Halyard Health
11.12. Mindray Medical International Limited
11.13. Micrel Medical Devices
11.14. Insulet Corporation
12. Appendix
12.1. Questionnaire
We are in the phase of updating this report by analysing the impact of COVID-19 on this market.
We are in the phase of updating this report by analysing the impact of COVID-19 on this market.
Published Date: Apr-2023
Published Date: Apr-2022
Published Date: Jan-2023
Published Date: Mar-2023
